Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-Fv)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-BAFF antibody variable domain is fused to the C terminal of an IgG of anti-IL17 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-Fv) (BSGV-019). Click the button below to contact us or submit your feedback about this product.